New Concepts in ACS: Beyond 2000 (XXIII)

Monday, October 23
7:00 – 8:45 AM

Vancouver, BC

Chair: Paul W. Armstrong

Co-Chair: Shaun Goodman

2017 Sponsors
of New Concepts in ACS: Beyond 2000 (XXII)

This symposium was co-developed with the Canadian Cardiovascular Society, Mazankowski Alberta Heart Institute/University of Alberta, Canadian VIGOUR Centre, AstraZeneca Canada Inc., and Merck Canada Inc., and was planned to ensure the evidence presented is valid, objective and balanced.

New Concepts in ACS: Beyond 2000 (XXIII)

Monday, October 23, 2017

Learning Objectives

  • Formulate a revised plan for lipid lowering in patients convalescing from acute coronary syndromes.
  • Apply reasoned risk-benefit considerations in choosing DAPT and oral anti-thrombotic therapy post-MI.
  • Integrating new data on the initial evaluation of the patient presenting with acute undifferentiated chest pain.
  • Incorporate new knowledge in acute coronary syndromes into current patient care.